Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis
CONCLUSIONS: These findings suggest that bivalirudin use during PCI reduced the risk of NACE and all-cause death but did not reduce the risk of MACE compared with heparin use in PCI. More studies specifically designed for anticoagulation strategies and a personalized anticoagulation regimen to comprehensively balance bleeding and ischemia risks are required.PMID:37964648 | DOI:10.5603/cj.90956 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Junyan Zhang Zhongxiu Chen Duolao Wang Chen Li Fangbo Luo Yong He Source Type: research
Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis
CONCLUSIONS: These findings suggest that bivalirudin use during PCI reduced the risk of NACE and all-cause death but did not reduce the risk of MACE compared with heparin use in PCI. More studies specifically designed for anticoagulation strategies and a personalized anticoagulation regimen to comprehensively balance bleeding and ischemia risks are required.PMID:37964648 | DOI:10.5603/cj.90956 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Junyan Zhang Zhongxiu Chen Duolao Wang Chen Li Fangbo Luo Yong He Source Type: research
Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis
CONCLUSIONS: These findings suggest that bivalirudin use during PCI reduced the risk of NACE and all-cause death but did not reduce the risk of MACE compared with heparin use in PCI. More studies specifically designed for anticoagulation strategies and a personalized anticoagulation regimen to comprehensively balance bleeding and ischemia risks are required.PMID:37964648 | DOI:10.5603/cj.90956 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Junyan Zhang Zhongxiu Chen Duolao Wang Chen Li Fangbo Luo Yong He Source Type: research
Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis
CONCLUSIONS: These findings suggest that bivalirudin use during PCI reduced the risk of NACE and all-cause death but did not reduce the risk of MACE compared with heparin use in PCI. More studies specifically designed for anticoagulation strategies and a personalized anticoagulation regimen to comprehensively balance bleeding and ischemia risks are required.PMID:37964648 | DOI:10.5603/cj.90956 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Junyan Zhang Zhongxiu Chen Duolao Wang Chen Li Fangbo Luo Yong He Source Type: research
